LeonaBio Net Income from 2010 to 2026

LONA Stock   4.79  0.07  1.48%   
LeonaBio's Net Loss is decreasing over the years with slightly volatile fluctuation. Net Loss is expected to dwindle to about -91.6 M. From 2010 to 2026 LeonaBio Net Loss quarterly data regression line had arithmetic mean of (36,173,371) and significance of  0.000027. View All Fundamentals
 
Net Loss  
First Reported
2019-03-31
Previous Quarter
-7 M
Current Value
-6.6 M
Quarterly Volatility
10.9 M
 
Covid
 
Interest Hikes
Check LeonaBio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among LeonaBio's main balance sheet or income statement drivers, such as Depreciation And Amortization of 945.8 K, Interest Expense of 29.4 M or Selling General Administrative of 19.3 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 0.48. LeonaBio financial statements analysis is a perfect complement when working with LeonaBio Valuation or Volatility modules.
  
Build AI portfolio with LeonaBio Stock
Check out the analysis of LeonaBio Correlation against competitors.
For information on how to trade LeonaBio Stock refer to our How to Trade LeonaBio Stock guide.
Analyzing LeonaBio's Net Income over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Net Income has evolved provides context for assessing LeonaBio's current valuation and future prospects.

Latest LeonaBio's Net Income Growth Pattern

Below is the plot of the Net Income of LeonaBio over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in LeonaBio financial statement analysis. It represents the amount of money remaining after all of LeonaBio operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is LeonaBio's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in LeonaBio's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported (96.94 M)10 Years Trend
Slightly volatile
   Net Income   
       Timeline  

LeonaBio Net Income Regression Statistics

Arithmetic Mean(36,173,371)
Coefficient Of Variation(119.34)
Mean Deviation38,460,950
Median(5,097,000)
Standard Deviation43,169,444
Sample Variance1863.6T
Range112.6M
R-Value(0.84)
Mean Square Error592.5T
R-Squared0.70
Significance0.000027
Slope(7,162,457)
Total Sum of Squares29817.6T

LeonaBio Net Income History

2026-91.6 M
2025-87.2 M
2024-96.9 M
2023-117.7 M
2022-95.6 M
2021-54.9 M
2020-20 M

Other Fundumenentals of LeonaBio

About LeonaBio Financial Statements

LeonaBio stakeholders use historical fundamental indicators, such as LeonaBio's Net Income, to determine how well the company is positioned to perform in the future. Although LeonaBio investors may analyze each financial statement separately, they are all interrelated. For example, changes in LeonaBio's assets and liabilities are reflected in the revenues and expenses on LeonaBio's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in LeonaBio. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Net Loss-87.2 M-91.6 M
Net Loss-87.2 M-91.6 M
Net Loss(28.97)(30.42)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether LeonaBio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of LeonaBio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Leonabio Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Leonabio Stock:
Check out the analysis of LeonaBio Correlation against competitors.
For information on how to trade LeonaBio Stock refer to our How to Trade LeonaBio Stock guide.
You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of LeonaBio. Expected growth trajectory for LeonaBio significantly influences the price investors are willing to assign. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive LeonaBio assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Understanding LeonaBio requires distinguishing between market price and book value, where the latter reflects LeonaBio's accounting equity. The concept of intrinsic value - what LeonaBio's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push LeonaBio's price substantially above or below its fundamental value.
Understanding that LeonaBio's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether LeonaBio represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, LeonaBio's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.